DATE:
TIME:
LINK: https://bit.ly/3OM3m93
Available for 1x1 meetings:
This will be a live, interactive online event where investors are invited to ask
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
Recent Genflow Highlights
- Genflow was awarded
2.89 million Euros in two new grants that will broaden its research pipeline and expand the size of its therapeutic markets over the next three years. (Please refer to press release here.) - Genflow to undertake key Investigational New Drug (IND)-enabling development activities that will help define the pharmacological and toxicological properties of its lead drug candidate, GF-1002, and its potential benefits for NASH patients.
- Initial site selection and QMS framework for clinical readiness, expected by the end of 2025 for its NASH program.
About
Founded in 2020,
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
CONTACTS:
Harbor Access
Investor Relations
+1 475 477 9401
Jonathan.Paterson@harbor-access.com
Virtual Investor Conferences
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com
Source: Virtual Investor Conferences
2024 GlobeNewswire, Inc., source